• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症护理中的预后沟通:文献系统综述

Communicating prognosis in cancer care: a systematic review of the literature.

作者信息

Hagerty R G, Butow P N, Ellis P M, Dimitry S, Tattersall M H N

机构信息

Medical Psychology Research Unit, School of Psychology and Department of Medicine, University of Sydney, NSW, Australia.

出版信息

Ann Oncol. 2005 Jul;16(7):1005-53. doi: 10.1093/annonc/mdi211. Epub 2005 Jun 6.

DOI:10.1093/annonc/mdi211
PMID:15939716
Abstract

Prognosis is an issue that most doctors and patients describe as difficult to discuss and the best way of presenting prognostic information to optimise patient understanding, psychological adjustment and decision-making is uncertain. A systematic review of the literature was conducted with the aim of clarifying the current available knowledge of patient preferences, clinician views and current practice regarding the communication of prognosis. Eleven primary research questions guided organisation of the review findings, which were: patient preferences for prognostic information and preferred style of communicating prognosis; disclosure of prognosis to family members; physicians' views on communication of prognosis; current practice of delivering prognostic information; patient understanding and awareness of prognostic information; cultural differences in preferences and understanding; impact of prognostic information on patient outcomes; and interventions to facilitate prognostic discussion. Predictors of patient preferences for and understanding of prognostic information were also summarised. Studies are summarised under the subcategories according to the participants' disease stage. It was found that the majority of the published research has been conducted in the early stage cancer setting providing mostly descriptive evidence, and there is little evidence of the best method of communicating prognosis or of the impact of prognostic information on patient outcomes.

摘要

预后是一个大多数医生和患者都认为难以讨论的问题,而以优化患者理解、心理调适和决策为目的呈现预后信息的最佳方式尚不确定。为了阐明目前关于患者偏好、临床医生观点以及预后沟通的现行做法的已有知识,开展了一项文献系统综述。十一个主要研究问题指导了综述结果的组织,这些问题是:患者对预后信息的偏好及传达预后的偏好方式;向家庭成员透露预后情况;医生对预后沟通的看法;传达预后信息的现行做法;患者对预后信息的理解和认知;偏好和理解方面的文化差异;预后信息对患者结局的影响;以及促进预后讨论的干预措施。还总结了患者对预后信息的偏好和理解的预测因素。研究根据参与者的疾病阶段在子类别下进行总结。结果发现,大多数已发表的研究是在癌症早期阶段进行的,大多提供描述性证据,几乎没有证据表明传达预后的最佳方法或预后信息对患者结局的影响。

相似文献

1
Communicating prognosis in cancer care: a systematic review of the literature.癌症护理中的预后沟通:文献系统综述
Ann Oncol. 2005 Jul;16(7):1005-53. doi: 10.1093/annonc/mdi211. Epub 2005 Jun 6.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.随机对照试验中参与者和专业人员偏好影响的概念框架与系统评价
Health Technol Assess. 2005 Sep;9(35):1-186, iii-iv. doi: 10.3310/hta9350.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Patient-doctor communication.医患沟通。
Med Clin North Am. 2003 Sep;87(5):1115-45. doi: 10.1016/s0025-7125(03)00066-x.
8
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.

引用本文的文献

1
Living with chronic kidney disease: future perspectives and prognostic needs of patients - a qualitative study.慢性肾病患者的生活:患者的未来展望与预后需求——一项定性研究
BMC Nephrol. 2025 Jul 1;26(1):301. doi: 10.1186/s12882-025-04243-8.
2
Start Time End Time Integration (STETI): Method for Including Recent Data to Analyze Trends in Kidney Cancer Survival.开始时间结束时间整合(STETI):纳入近期数据以分析肾癌生存趋势的方法。
Healthcare (Basel). 2025 Jun 17;13(12):1451. doi: 10.3390/healthcare13121451.
3
Having hard conversations: Advance care planning, serious illness conversations, and goals of care discussions with oncology patients.
进行艰难对话:与肿瘤患者进行预先护理规划、重病对话及护理目标讨论。
Can Fam Physician. 2025 Feb;71(2):117-120. doi: 10.46747/cfp.7102117.
4
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians.肉瘤治疗中临床决策的风险预测模型:一项针对软组织肉瘤临床医生的国际调查
Ann Surg Oncol. 2025 Apr;32(4):2958-2970. doi: 10.1245/s10434-024-16849-7. Epub 2025 Feb 1.
5
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial.转移性葡萄膜黑色素瘤的早期姑息治疗(早期联合):一项前瞻性随机III期试验方案
Melanoma Manag. 2024 Dec;11(1):2382080. doi: 10.1080/20450885.2024.2382080. Epub 2024 Aug 8.
6
A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?一份关于导致癌症患者临终过度治疗因素的分类法。问题是什么?为何会发生?如何解决?
ESMO Open. 2025 Jan;10(1):104099. doi: 10.1016/j.esmoop.2024.104099. Epub 2025 Jan 6.
7
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.促进晚期难治性癌症患者与肿瘤学家的沟通:问题提示清单的开发与可行性测试
Pilot Feasibility Stud. 2024 Aug 28;10(1):116. doi: 10.1186/s40814-024-01543-y.
8
MSFN: a multi-omics stacked fusion network for breast cancer survival prediction.MSFN:一种用于乳腺癌生存预测的多组学堆叠融合网络。
Front Genet. 2024 Aug 2;15:1378809. doi: 10.3389/fgene.2024.1378809. eCollection 2024.
9
Parent and oncologist perspectives on prognostic disclosure in advanced childhood cancer: communication pearls and pitfalls.家长和肿瘤医生对晚期儿童癌症预后告知的观点:沟通要点和误区。
Support Care Cancer. 2024 May 13;32(6):341. doi: 10.1007/s00520-024-08539-7.
10
The stigma towards mental illness: Portuguese validation of the Opening Minds Stigma Scale for Healthcare Providers (OMS-HC).对精神疾病的污名化:《医疗服务提供者开放心态污名量表》(OMS-HC)在葡萄牙的验证
Front Psychol. 2024 Mar 7;15:1359483. doi: 10.3389/fpsyg.2024.1359483. eCollection 2024.